United Therapeutics UTHR announced that the FDA has issued a complete response letter to its new drug application (“NDA”) for its drug device combination therapy, Tyvaso Dry Powder Inhaler or ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021/ PRNewswire/-- United Therapeutics Corporation announced today that it has launched commercial sales of the innovative Remunity ...

Jefferies analyst Eun Yang maintained a Buy rating on United Therapeutics (UTHR - Research Report) on October 20 and set a price target of $260.00. The companys shares opened today at $220.83 ...